HEALTH

Survey: HSA participants are more engaged in managing their health

BY Michael Johnsen

NEW YORK — Employees who contribute to health savings accounts generally become more engaged in managing their health after enrolling, according to a survey conducted by Buck Consultants, a Xerox Company.

For example, 51% of respondents set aside more money for potential medical costs than before they had HSAs. As many as 29% have more discussions with their doctors about the cost of care and 13% more actively manage their chronic disease.

“In fact, respondents indicated greater engagement with each of 11 health management activities measured,” said Travis Klavohn, director, Consumer Health Solutions, BenefitWallet, a Xerox Solution. “Remarkably, these results are consistent across our three surveys conducted over a five-year period.”

HSA members are responsible for a greater portion of their health costs, so they expect tools to help them make informed, rational decisions. When ranking important HSA product features, 44% of respondents ranked the ability to view claims on the HSA site as most important. They ranked paying medical claims on the HSA member portal second at 35%.

“HSA members are making wiser health care decisions,” Klavohn said. “They are evaluating costs more closely before receiving care, shopping for lower priced drugs and choosing less costly services. They attribute their changed behavior to owning an HSA.”

The BenefitWallet: 2013 Member Survey Report found that the vast majority (90%) of HSA members obtain medical coverage through their employer. And more employers are contributing to HSAs (75%).

The survey, which polled more than 23,000 members of BenefitWallet, identifies behaviors, opinions and demographics of individuals who own HSAs.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Walgreens: Flu disrupted vacation plans for 11 million Americans in 2012

BY Michael Johnsen

DEERFIELD, Ill. — More than 11 million Americans had vacation plans disrupted by the flu in 2012, according to Walgreens’ recent Impact Survey, the company announced Tuesday.   

"It is important to remember that the vaccine doesn’t just protect the person getting a flu shot, it helps to protect friends, family, co-workers and others with whom they’re coming in contact," said Harry Leider, Walgreens chief medical officer. "This time of year, germs and viruses can easily spread as people travel, gather for the holidays and enjoy other seasonal community activities. Last year we saw the widespread effect this can have for those who maybe didn’t take the proper preventive measures." 

The Walgreens Flu Impact Report found that last year’s severe flu season significantly impacted holiday events in general, with 17 million of them cancelled or interrupted, based on survey projections. The 2012-2013 flu season was one of the most severe in the United States in more than a decade and, according to the study, had three times the impact than a more typical flu season on travel and holiday plans.

The Flu Impact Survey was conducted online within the United States by USamp on behalf of Walgreens from Aug. 27 to Sept. 4, 2013, among 1,200 nationally representative adults ages 18 years and older.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Absorption Pharmaceuticals to conduct clinical trials of Promescent with Kaiser

BY Michael Johnsen

NEW YORK — Absorption Pharmaceuticals will be conducting clinical trials with Kaiser to measure the efficacy of the company’s over-the-counter solution for PE Promescent, CNBC reported Tuesday. 

Beginning next week, Kaiser will follow 150 men who suffer from premature ejaculation and will be given either Promescent or a placebo over the course of the next year. Patients are being recruited from the San Diego and Los Angeles markets, according to the report.  

Absorption has also released a new commercial in support of Promescent. 

keyboard_arrow_downCOMMENTS

Leave a Reply

T.Peters says:
Dec-10-2013 05:24 pm

I have been following Promescent since they had an article come out last October on CNBC. The product was developed by Urologists and is rapidly becoming the treatment embraced by the medical community. It has an absorption technology that penetrates the top layer of skin and desensitizes the nerves in the penis. Promescent has no transference to your partner, allows the men retain sensation, is safe and easy to use. Promescent seems to offers a legitimate medical solution to those with PE or to those who would just like to prolong the experience. Wish I had developed this product, so much potential. Here is a link to the old CNBC article as well as another one that came out this morning. http://www.cnbc.com/id/101084377 http://www.cnbc.com/id/101260806

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?